Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

State Street SPDR S&P Biotech ETF (NY:XBI)

114.53 +2.62 (+2.34%)
Streaming Delayed Price Updated: 1:18 PM EST, Nov 14, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about State Street SPDR S&P Biotech ETF

< Previous 1 2 3 4 5 6 7 8 9
...
14 15 Next >
News headline image
AskSlim Market Week - Friday, July 12 ↗
An analysis and commentary on the financial markets. 
Via Talk Markets
News headline image
Stocks Are Breaking Down Beneath The Surface ↗
Stocks and sectors are showing real signs of weakness despite the headline indexes going higher. 
Via Talk Markets
News headline image
Healthcare Stocks Continue To Lag The Market-Can Anything Help ? ↗
Healthcare stocks continue to lag the market up about 6% YTD, helped by Large Cap Biopharma but hurt by United Health. 
Via Talk Markets
News headline image
Top Performing Industry ETFs In June: Software Leads Returns, Chipmakers Attract Most Inflows ↗
June saw gains in the U.S. stock market, with tech and biotech leading the way. Semiconductor ETFs saw strong inflows, while utilities lagged. 
Via Benzinga
Topics ETFs
News headline image
AskSlim Market Week - Friday, March 28 ↗
An analysis and commentary on the financial markets. 
Via Talk Markets
News headline image
5 Biotech Stocks With Key Catalysts This Week: Merck, Intellia, Verona, And More ↗
Biotech investing is risk-fraught but the returns could be staggering if one chooses to take the educated approach. 
Via Benzinga
News headline image
Soft Inflation Data Boosts Small Caps, Real Estate, Regional Banks; Traders Anticipate Fed Rate Cuts As Stocks React ↗
U.S. inflation slowed in May, boosting rate cut prospects. Markets rally ahead of FOMC meeting and assign 70% chance of rate cut in September. 
Via Benzinga
Topics Economy
News headline image
Healthcare And Biotech Investing: Breakthroughs In The Treatment Of Cancer At ASCO ↗
Healthcare stocks underperformed YTD because of weakness in UNH and strength in Technology and Communication Services. 
Via Talk Markets
News headline image
June’s Biotech Boom: 3 Stocks to Buy for a Summertime Surge ↗
Biotech surge alert! Discover three biotech stocks to buy as they catch up with the market in the rest of 2024. 
Via InvestorPlace
News headline image
American Express, Trade Desk And More: CNBC's 'Final Trades' ↗
American Express Company has "above market growth for below market multiple," Amy Raskin of Chevy Chase Trust said. 
Via Benzinga
News headline image
The 3 Most Undervalued Biotech Stocks to Buy in June 2024 ↗
https://seekingalpha.com/news/4111624-goldman-sachs-raises-obesity-drug-market-estimate 
Via InvestorPlace
News headline image
Should I Be Worried? Stock Market (And Sentiment Results)… ↗
We are aggressively putting money to work in individual companies that are excessively undervalued relative to what we believe their normalized earnings power will look like as their recoveries... 
Via Talk Markets
News headline image
If You Can Only Buy One Biotech Stock in May, It Better Be One of These 3 Names ↗
Between FDA approvals and product pipelines, it takes diligence to keep up with which biotech stocks to buy. 
Via InvestorPlace
News headline image
Why the Rest of 2024 Could Be Good for Investing in Biotech Stocks ↗
Investors have been ignoring biotech stocks for far too long. Here's why they could start to heat up in 2024. 
Via InvestorPlace
News headline image
For Biotech Stocks To Move Higher, This Must Move Lower ↗
While biotechs have significantly lagged behind the broader market, there is reason to be optimistic once inflation-related volatility subsides. IBB and XBI present good vehicles for biotech exposure. 
Via Talk Markets
News headline image
Elon Musk Breaks Ranks With GOP By Praising Genetic Engineering Tech That Helped Fight COVID-19: 'Digital Medicine With Incredible Potential' ↗
Elon Musk has come off as a flagbearer of the mRNA technology, which is seen holding out a lot of promise by scientists. 
Via Benzinga
News headline image
AskSlim Market Week - Friday, April 26 ↗
An analysis and commentary on the financial markets. 
Via Talk Markets
News headline image
3 Biotech Stocks That Could Be Multibaggers in the Making: April Edition ↗
Many fortunes have been made with a fortuitous investment in a biotech stock at the right time. That time might be now. 
Via InvestorPlace
News headline image
Healthcare Stocks Are Lagging With Big Earnings Weeks Ahead ↗
Healthcare stocks disappointed again last week with the XLV down over 3% and up only 1.65 % YTD, in a continued downtrend since March 28. 
Via Talk Markets
News headline image
Clean Energy, Semiconductors Among Interest-Rate-Sensitive Sectors Hammered Thursday Afternoon On Rate Cut Concerns ↗
Stocks initially rose on positive jobless claims report, but dropped later as Fed officials expressed doubts about interest rate cuts this year. 
Via Benzinga
Topics Economy
News headline image
5 Healthcare Stocks to Buy for 2024 ↗
Healthcare stocks have been some of the top performers in 2024, and thanks to the potential of AI, these names will just keep heating up. 
Via InvestorPlace
Topics Artificial Intelligence
News headline image
Healthcare And Biotech Stocks Review: Q1 2024 Performance ↗
We just had one of the best first quarters in recent market history since Q1 in 2019 when the market was up 13%. But changes in sector performance may be coming. The S&P 500 was up 10% showing a slight... 
Via Talk Markets
Topics Stocks
News headline image
2 Top Biotech Buyout Candidates ↗
Investors who are adventurous, have a high-risk tolerance, and are home run hitters may opt for biotech stocks. Investors in this group may want to hone in on stocks that have the potential to be... 
Via Talk Markets
News headline image
3 Top ETFs I Plan to Buy in April ↗
These ETFs are easy, low-cost ways to invest in certain themes. 
Via The Motley Fool
Topics ETFs
News headline image
3 Biotech Stocks to Buy on the Dip: March 2024 ↗
Some of the best opportunities can be found in dips in some of the top biotech stocks to buy. In fact, here are three. 
Via InvestorPlace
News headline image
Tuesday Talk: Big-Tech Under Attack ↗
On Thursday the Justice Dept. filed an antitrust suit against Apple. The suit joins two others already filed against Google. How much this will affect the market in the long run is up for grabs. 
Via Talk Markets
News headline image
Biotechnology And Healthcare, A Bit Of A Lull ↗
Strong momentum of Tech and Chip stocks may be too good of a distraction for biotech investors. 
Via Talk Markets
News headline image
3 Biotech ETFs Overdue for a Bounce ↗
The biotech ETFs have been under serious pressure in recent years. Newfound momentum and looming lower rates could spark a comeback. 
Via InvestorPlace
Topics ETFs
News headline image
It's A Bull Market But Harder To Pick Small Cap Biotech Winners Because Of Volatility ↗
Biotech is in a bull market aș measured by 2023 trends with a double testing of lows on 11/23. 
Via Talk Markets
News headline image
Are We Listening To The Market's Message? ↗
This week's video features chart/fact-based Q & A covering major stock market indexes, ETFs, the economy, homebuilders, regional banks, semiconductors, value stocks, energy stocks, biotech, and more. 
Via Talk Markets
Topics ETFs Economy
< Previous 1 2 3 4 5 6 7 8 9
...
14 15 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.